Vanberra Signal

DyNAbind

Curated by Signal

Developer of DNA-Encoded Library drug discovery

Overview

Developer of DNA-Encoded Library drug discovery. The company offers a proprietary technology platform, that helps partners to have medicinal chemistry starting points for various protein targets, including traditional classes like protein-protein interactions. The platform allows users to simultaneously select from hundreds of millions of molecules.

Key facts

Founded
2017
Headquarters
Dresden, Germany

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of cell analyzer cell image analysis

    Life Sciences TechnologyMunich, Germany
  • Products portfolio for in-vitro fertility

    Life Sciences TechnologyRheinbach, Germany
  • Developer of prosthetic devices for orthopedic support

    Life Sciences TechnologyKarlsruhe, Germany

About DyNAbind

What does DyNAbind do?

Developer of DNA-Encoded Library drug discovery.

Where is DyNAbind headquartered?

DyNAbind is headquartered in Dresden, Germany.

When was DyNAbind founded?

DyNAbind was founded in 2017.

Which sector is DyNAbind in?

DyNAbind operates in Life Sciences Technology.

Who are DyNAbind's competitors?

Companies similar to DyNAbind include BioDataAnalysis, Reproline Medical, and Vincent Systems.